Company Outset Medical, Inc.

Equities

OM

US6901451079

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
2.4 USD +0.84% Intraday chart for Outset Medical, Inc. +3.45% -55.64%

Business Summary

Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.

Number of employees: 480

Sales per Business

USD in Million2022Weight2023Weight Delta
Consoles
47.0 %
65 56.0 % 61 47.0 % -5.05%
Consumables
32.4 %
29 25.0 % 42 32.4 % +46.56%
Service and Other
20.6 %
22 19.1 % 27 20.6 % +22.07%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
115 100.0 % 130 100.0 % +13.00%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 31/08/13
Director of Finance/CFO 48 30/04/20
Chief Tech/Sci/R&D Officer - 22/06/21
Chief Tech/Sci/R&D Officer - 31/08/18
Investor Relations Contact - 31/12/21
General Counsel - 30/04/20

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 53 31/08/13
Director/Board Member 63 30/04/19
Director/Board Member 63 31/03/14
Director/Board Member 64 07/01/21
Director/Board Member 56 31/01/20
Director/Board Member 66 23/03/21
Director/Board Member 64 24/04/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 51,702,159 50,760,348 ( 98.18 %) 0 98.18 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
13.99 %
7,066,782 13.99 % 16 M $
Columbia Wanger Asset Management LLC
10.12 %
5,112,408 10.12 % 11 M $
JPMorgan Investment Management, Inc.
9.823 %
4,961,199 9.823 % 11 M $
Vanguard Fiduciary Trust Co.
7.804 %
3,941,367 7.804 % 9 M $
Morgan Stanley Investment Management, Inc.
7.659 %
3,868,064 7.659 % 9 M $
BlackRock Advisors LLC
7.263 %
3,668,090 7.263 % 8 M $
T. Rowe Price Investment Management, Inc.
6.270 %
3,166,747 6.270 % 7 M $
Columbia Wanger Asset Management LLC
5.905 %
2,982,490 5.905 % 7 M $
Braidwell LP
4.753 %
2,400,427 4.753 % 5 M $
Bellevue Asset Management AG
3.485 %
1,760,134 3.485 % 4 M $

Company contact information

Outset Medical, Inc.

3052 Orchard Drive

95134, San Jose

+

http://www.outsetmedical.com
address Outset Medical, Inc.(OM)
  1. Stock Market
  2. Equities
  3. OM Stock
  4. Company Outset Medical, Inc.